4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-059302
President and CEO sold 21,268 shares at an average $18.00 ($382,874)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2019-12-03 | Sale | −2,513 | $18.02 | $45,284 | 2,448,059 | I |
| Watts Ryan J. President and CEO | 2019-12-04 | Sale | −18,755 | $18.00 | $337,590 | 2,429,304 | I |
| Open-market sales · 21,268 sh · avg $18.00 · $382,874 | |||||||
Loading xslF345X03/doc4.xml…